Wellness
Women's Hormone Therapy (BHRT) in San Jose: Cost & Best Providers (2026)
· 7 min read · Bay Area Med Spa Guide Editorial

Hormone therapy for perimenopause and menopause runs $30–$500/month in San Jose depending on the formulation. A major FDA safety update in February 2026 changed how this treatment is understood — here's what actually changed and what didn't.
Quick answer
Hormone therapy for women (including bioidentical hormone replacement therapy, or BHRT) in San Jose costs $30–$500/month depending on the formulation — standard FDA-approved hormone products run $30–$120/month, compounded bioidentical formulations run $100–$350/month, and pellet therapy runs $350–$500 per insertion every 3–4 months. In February 2026, the FDA removed cardiovascular, breast cancer, and dementia boxed-warning language from menopausal hormone therapy products — a real, significant update to decades-old warning language. The endometrial cancer warning for estrogen-alone products was not removed. We track 31 verified San Jose providers; True You Aesthetic currently has the most reviews in our data (553) at a 4.9★ rating.
What Does Hormone Therapy Cost for Women in San Jose?
Hormone therapy for perimenopause and menopause in San Jose runs $30–$500/month, and the range depends heavily on which formulation you use. Standard FDA-approved hormone products (pills, patches) run $30–$120/month. Compounded bioidentical hormone therapy — custom-mixed by a pharmacy, not FDA-approved — runs $100–$350/month and is rarely covered by insurance. Pellet therapy (implantable options like Biote or SottoPelle) runs $350–$500 per insertion, typically needed every 3–4 months. We track 31 verified San Jose providers — True You Aesthetic currently has the most Google reviews in our data at 553, with a 4.9★ rating, if you want a specific starting point for comparison.
A Major Safety Update: What Changed in February 2026
The regulatory picture around menopausal hormone therapy shifted significantly this year, and it's worth understanding what actually changed.
In February 2026, the FDA removed boxed-warning language describing cardiovascular disease, breast cancer, and dementia risk from menopausal hormone therapy products, following a comprehensive review of updated clinical evidence, an expert panel, and a public comment period. This is a real, evidence-driven change to warning language that had shaped how both patients and providers approached this treatment for decades.
What didn't change: the endometrial cancer warning for systemic estrogen-alone products was not removed and still applies. This distinction matters — the update reflects updated evidence on specific risks, not a blanket "hormone therapy has no risks" conclusion.
What the updated guidance emphasizes: starting hormone therapy before age 60 or within 10 years of menopause onset is associated with the best benefit-risk balance — including potential reductions in fracture risk, all-cause mortality, and cognitive decline. This timing consideration is now a specific part of the FDA's labeling emphasis, not just general clinical opinion, and it's a genuinely worthwhile question to bring up with your provider if you're further out from menopause onset.
Compounded BHRT vs. FDA-Approved Hormone Therapy
"Bioidentical" doesn't automatically mean safer or more effective — it's a formulation choice, not a different risk category. FDA-approved hormone products go through FDA testing and approval and are generally the lower-cost option. Compounded bioidentical hormone therapy is custom-mixed by a pharmacy specifically for you, is not FDA-approved as a finished product, and typically costs more, with insurance rarely covering it.
Neither option is inherently "more natural" in a way that changes the underlying medical risk profile. If a San Jose provider recommends a compounded formulation over an FDA-approved one, it's reasonable to ask specifically why — a legitimate reason (a specific dose or combination not commercially available) is different from a marketing preference for "bioidentical" language.
What to Ask Before You Start
Confirm what formulation is being recommended (FDA-approved vs. compounded) and why. Ask what baseline labs and history review happen before starting, and how follow-up is scheduled. If you're more than 10 years past menopause onset or over 60, ask your provider directly how that affects the recommended approach given current guidance.
This article provides general information about hormone therapy pricing and providers for women in San Jose. It is not medical advice. Hormone therapy requires medical evaluation and is not appropriate for everyone. Individual candidacy, formulation choice, and exact pricing should always be confirmed directly with a licensed provider during a consultation.
For Patients
Find the right Bay Area clinic for you
Get our vetted clinic picks, real pricing ranges, and treatment guides — straight to your inbox.
Or get matched with a provider now →For Med Spa Owners
Reach thousands of Bay Area patients
List your clinic on Bay Area Med Spa Guide and get in front of high-intent patients actively searching for providers like you.
- ✓ Free to list — no upfront cost
- ✓ Appear in city and treatment searches
- ✓ Featured placement available
Frequently asked questions
Editorial content only — not medical advice. Consult a licensed provider before starting treatment.